paromomycin has been researched along with Dientamoeba fragilis Infection in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abellana, R; Burgaña, A; García-Puig, R; Gonçalves, AQ; Hernández, CG; Kazan, R; Padilla, E; Pérez Ortiz, AM; Pérez, J; Perez-Porcuna, TM; Ramos, CC; Rivero, MM; Yordanov, SZ | 1 |
Carlet, R; Clemente, L; Fontana, F; Pasut, M; Ruscio, M | 1 |
Boga Ribeiro, JA; Fernández-Suarez, J; Gonzalez-Sotorrios, N; Menéndez, C; Rodríguez-Guardado, A; Rodríguez-Pérez, M; Vázquez, F | 1 |
Dediste, A; Mouchet, F; Souayah, H; van Gool, T; Vandenberg, O | 1 |
Wolfe, MS | 1 |
1 review(s) available for paromomycin and Dientamoeba fragilis Infection
Article | Year |
---|---|
The treatment of intestinal protozoan infections.
Topics: Amebicides; Antimalarials; Antiprotozoal Agents; Balantidiasis; Chloroquine; Coccidiosis; Dientamoebiasis; Drug Combinations; Dysentery, Amebic; Emetine; Furans; Furazolidone; Giardiasis; Humans; Intestinal Diseases, Parasitic; Iodoquinol; Liver Abscess, Amebic; Metronidazole; Paromomycin; Quinacrine; Sulfamethoxazole; Tetracycline; Tinidazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
4 other study(ies) available for paromomycin and Dientamoeba fragilis Infection
Article | Year |
---|---|
Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Dientamoeba; Dientamoebiasis; Feces; Female; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Paromomycin; Spain; Treatment Outcome; Young Adult | 2019 |
Dientamoeba fragilis in the North-East of Italy: Prevalence study and treatment.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Child, Preschool; Cross-Sectional Studies; Dientamoeba; Dientamoebiasis; Female; Humans; Infant; Italy; Male; Metronidazole; Middle Aged; Paromomycin; Prevalence; Young Adult | 2021 |
Epidemiological and clinical characteristics of Dientamoeba fragilis infection.
Topics: Adult; Antiprotozoal Agents; Dientamoebiasis; Female; Humans; Male; Metronidazole; Middle Aged; Paromomycin; Retrospective Studies; Young Adult | 2019 |
Treatment of Dientamoeba fragilis infection with paromomycin.
Topics: Adolescent; Amebicides; Animals; Child; Child, Preschool; Dientamoeba; Dientamoebiasis; Female; Gastrointestinal Diseases; Humans; Infant; Male; Paromomycin | 2007 |